Workflow
Short interest
icon
Search documents
Why Avis Budget Group Stock Zoomed Ahead Today
The Motley Fool· 2026-03-26 23:41
A well-timed marketing campaign and chaos at U.S. airports are among the factors making Avis Budget Group (CAR +12.96%) shares very attractive to investors these days. On Thursday, the auto rental conglomerate's stock surged 13% on a generally gloomy day for the market.Time to hit the roadThe current political impasse over the continued funding of the Department of Homeland Security (DHS) has directly affected the functioning of airports. The Transportation Security Administration (TSA) is a sub-agency of t ...
FCC Ban Triggers Overdue NetGear Stock Surge
Schaeffers Investment Research· 2026-03-24 14:32
Wi-Fi router manufacturer NetGear Inc (NASDAQ:NTGR) is surging 9.8% higher this morning, last seen at $24.23, headed for its best daily pop since August. Driving today's gains is news the Federal Communications Commission (FCC) has banned all imports of foreign routers, citing national security risks.Today's bull gap has NTGR contending with its year-to-date breakeven mark, trading at levels not seen since December. Gains could be capped by the 260-day moving average, however, which sits just overhead.Short ...
Aerospace Stock Surges on Successful Flight Launch
Schaeffers Investment Research· 2026-03-12 14:04
Firefly Aerospace Inc (NASDAQ:FLY) stock is up 15.3% to trade at $23.75 at last glance, after the company announced it launched its Alpha Flight 7 successfully. This comes after several failed attempts to launch the rocket into orbit last year, including an explosion in September.Now trading at its highest level since February, FLY is bouncing off a floor at the $18 level to break above the 20-day moving average, which had been acting as pressure in the last few weeks. The security is also testing resistanc ...
Why Are Carvana Shares Sliding On Friday? - Carvana (NYSE:CVNA)
Benzinga· 2026-03-06 18:40
Core Insights - Carvana Co. (NYSE:CVNA) experienced a decline in stock price due to rising short interest and concerns from its recent earnings report [1][2] Short Interest - Short interest in Carvana increased from 14.84 million to 15.17 million shares, representing 12.1% of publicly available shares [2] - With an average daily volume of 3.82 million shares, it would take nearly four days for short sellers to exit without causing a spike in the stock price [2] Earnings Report - Carvana reported fourth-quarter revenue of $5.60 billion, exceeding analyst expectations of $5.26 billion [3] - Earnings per share were $4.22, with vehicle sales increasing by 43% year-over-year, totaling 163,522 units sold [3] - Total revenue surged by 58% annually [3] Cost Concerns - A report indicated higher-than-expected costs related to vehicle inspections, repairs, and detailing, which negatively impacted investor sentiment [4] - Rising retail depreciation also affected per-unit economics [4] Technical Analysis - Carvana's stock is trading 9.9% below its 20-day simple moving average (SMA) and 17.9% below its 100-day SMA, indicating short-term bearishness [5] - Over the past 12 months, the stock has risen by 68.34%, currently priced at $316.89, above its 52-week low of $148.25 but below its high of $486.89 [5] Relative Strength Index - The Relative Strength Index (RSI) is at 39.53, suggesting neutral momentum [6] Upcoming Earnings - Carvana is scheduled to provide its next financial update on May 6 [7] Analyst Ratings - The stock carries a Buy Rating with an average price target of $438.68 [8] - Recent analyst actions include Citigroup lowering its target to $465.00, Barclays lowering to $450.00, and DA Davidson lowering to $320.00 [8]
What's Going On With Novavax Stock On Friday?
Benzinga· 2026-02-27 19:20
Core Insights - Novavax Inc. reported a fourth-quarter profit of $0.11 per share, a significant improvement from a loss of $0.51 per share a year ago, with revenue reaching $147 million, marking a 67% year-over-year increase [2] - The company projected adjusted total revenue for 2026 to be between $230 million and $270 million, which is below the consensus estimate of $381.22 million [2] - Novavax's R&D and SG&A expenses are expected to be $325 million in 2026, $225 million in 2027, and $200 million or less in 2028 [3] Stock Performance - Novavax shares experienced a decline of 11.30% to $9.93, following a profit-taking trend after a previous rally [6] - The stock is currently trading 8.4% above its 20-day simple moving average (SMA) and 9.2% above its 100-day SMA, indicating short-term strength despite the recent downturn [4] - Over the past 12 months, shares have shown significant growth and are closer to their 52-week highs than lows [4] Technical Indicators - The Relative Strength Index (RSI) is at 44.45, indicating a neutral position, suggesting the stock is neither overbought nor oversold [5] - The absence of significant MACD crossovers indicates a stable trend without immediate bullish or bearish pressure, suggesting mixed momentum [5] Analyst Consensus - The stock carries a Hold rating with an average price target of $32.62 [6] - Recent analyst actions include HC Wainwright & Co. upgrading to Buy and raising the target to $16.00 [6] - Key resistance level is identified at $11.50, while key support is at $9.00 [6]
Krispy Kreme Shares Surge 30% After Q4 Earnings and Revenue Beat
Financial Modeling Prep· 2026-02-26 22:36
Core Viewpoint - Krispy Kreme Inc. reported fourth-quarter results that exceeded Wall Street expectations for both earnings and revenue, leading to a significant increase in share price [1][2] Financial Performance - The company recorded net revenue of $392.4 million for the quarter, surpassing the analyst estimate of $386.7 million [1] - Adjusted earnings per share were $0.09, outperforming expectations of $0.03 [1] Market Sentiment - Management attributed the strong performance to robust consumer demand for its signature fresh doughnuts [2] - The company has a notable short interest, with approximately 12.8% of its free float sold short, indicating bearish positioning by investors [2] - The stronger-than-expected results provided momentum for the stock, which had previously faced pressure from short sellers [2]
Michael Saylor's MSTR Becomes World's Most Shorted Stock — But Why Does Tom Lee Think This Is A Bullish Signal For Bitcoin? - Coinbase Global (NASDAQ:COIN)
Benzinga· 2026-02-25 03:33
Core Viewpoint - The surge in short interest for Strategy Inc. (NASDAQ:MSTR) is interpreted as a contrarian bullish signal by Wall Street analyst Tom Lee, suggesting that the stock may rally despite negative sentiment due to its status as a "consensus" short [1][2]. Group 1: Short Interest and Market Sentiment - Strategy Inc. has become the most shorted large-cap U.S. stock, indicating a crowded trade as investors bet against its Bitcoin strategy [2]. - Renowned investor Steve Eisman has also disclosed that he is shorting Strategy stock, adding to the bearish sentiment surrounding the company [3]. Group 2: Financial Performance and Analyst Ratings - The company is facing unrealized losses of nearly $7 billion on Bitcoin, which is central to its business model [4]. - Over the last six months, MSTR shares have declined more than 63%, which is worse than Bitcoin's decline during the same period [4]. - Despite the bearish sentiment, the most recent analyst ratings for MSTR are bullish, with an average price target of $254, more than double the current stock price [4]. Group 3: Price Action - As of the latest data, Bitcoin (BTC) is trading at $65,948.87, reflecting a 3.35% increase over the last 24 hours [5]. - MSTR shares fell 0.17% in after-hours trading after closing 0.73% higher at $124.61 during the regular trading session [5]. - The stock exhibits weak price momentum across short-, medium-, and long-term periods, resulting in a very low Momentum score in Benzinga's Edge Stock Rankings [5].
Buy the Dip on This Biotech Stock After Recent Fall
Schaeffers Investment Research· 2026-02-09 19:44
Core Insights - BridgeBio Pharma Inc (NASDAQ:BBIO) experienced a significant stock pullback from its record high of $81.33 on January 22, reaching a three-month low after Pfizer withdrew a tafamidis patent in the European Union [1] - Despite the pullback, shares were observed trading up 5.2% at $71.57, indicating underlying strength supported by technical indicators such as the ascending 100-day moving average [1] Technical Analysis - BBIO is currently within 0.75 of its 100-day moving average's 20-day average true range (ATR), having remained above this level 80% of the time over the past two weeks and 80% of the last 42 trading sessions [2] - Historical data shows that similar signals have occurred six times in the past decade, with BBIO being higher one month later 67% of the time, averaging a gain of 7%, which could position the stock at $76.58 [2] Market Sentiment - Short interest in BBIO has been increasing, now representing 11% of the stock's available float, equating to nearly eight days' worth of potential buying power [3] - The 10-day put/call volume ratio at major exchanges indicates that BBIO's current sentiment is more pessimistic, sitting higher than 77% of readings from the past year [3]
Wall Street traders show their hands with bets on Warner Bros. Discovery-Netflix deal
New York Post· 2026-01-30 15:04
Core Viewpoint - Wall Street traders are increasingly optimistic about Warner Bros. Discovery (WBD) being sold to Netflix, with a significant reduction in short interest in the stock, indicating a shift in sentiment towards the company's future prospects [1][6]. Group 1: Short Interest Trends - WBD had experienced a rise in short interest throughout the year, making it one of the most heavily shorted entertainment stocks [2]. - Short interest has decreased from 6% in July to just 3% of the float, with traders covering approximately 30 million shares over the past month [7]. Group 2: Company Performance and Strategy - Under CEO David Zaslav's leadership, WBD has made significant improvements, including making HBO Max profitable, producing successful films, and reducing debt [5][6]. - The company's stock price has recovered from near penny stock levels to around $12, reflecting improved investor confidence [6]. Group 3: Regulatory Considerations - Despite the positive sentiment, there are concerns regarding the regulatory approval process for the potential sale to Netflix, which could take up to two years [8][10]. - Officials in the EU and UK are also expressing concerns about Netflix's market power, which could impact the deal's timeline and lead to a resurgence in short interest if delays occur [11].
Ignore Small-Cap Stocks at Your Own Opportunity Cost
Schaeffers Investment Research· 2026-01-26 14:18
Core Viewpoint - The market is experiencing a rotation from large-cap technology stocks to small-cap stocks, with the Russell 2000 Index (RUT) reaching all-time highs, indicating potential bullish sentiment in the market [1][2]. Group 1: Market Trends - Strong net inflows into global equity funds were observed, particularly in US and emerging market equity funds, totaling $71 billion compared to only $2 billion the previous week, marking a significant increase [2]. - The RUT has outperformed the S&P 500 Index (SPX), with a 7% increase in 2026 despite a 2% pullback on one day, while the SPX has struggled to maintain its late-October all-time high [3][6]. - The SPX has been rangebound since mid-November, primarily due to a rotation out of mega-cap technology stocks into smaller, underperforming stocks from the previous year [4][5]. Group 2: Technical Analysis - The SPX has not made significant progress relative to its late October highs, while the RUT has rallied over 10%, indicating a divergence in performance between small and large-cap stocks [6][9]. - The SPX is currently near all-time highs with multiple support levels below, including the 2025 close and its 80-day moving average, but faces technical resistance just overhead [9]. - High short interest in RUT components suggests potential opportunities in sectors outside the mega-cap technology group, which is currently weighing down the SPX [9][10].